We’re proud to introduce our latest Patient Service Announcement, 'Family Dinner,' where Olivia—based on real-life patient advocate Terri—returns to help her family understand the risks and dangers of liver scarring.
Madrigal Pharmaceuticals
制药业
Conshohocken,Pennsylvania 48,067 位关注者
Madrigal is focused on developing therapeutics to improve the lives of patients with metabolic and fatty liver diseases.
关于我们
Madrigal (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the treatment of adults with NASH with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) and is being studied in a Phase 3 trial for the treatment of NASH with compensated cirrhosis. For more information, visit www.madrigalpharma.com.
- 网站
-
https://www.madrigalpharma.com/
Madrigal Pharmaceuticals的外部链接
- 所属行业
- 制药业
- 规模
- 201-500 人
- 总部
- Conshohocken,Pennsylvania
- 类型
- 上市公司
- 创立
- 2016
- 领域
- Liver Disease、NASH、Metabolic Disease和MASH
地点
-
主要
200 Barr-Harbor Dr
Suite 200
US,Pennsylvania,Conshohocken,19428
Madrigal Pharmaceuticals员工
动态
-
Nearly 100 people attended Madrigal’s #NASH / #MASH Community Voices Listening Session on Thursday, Nov. 14 in San Diego, including 80 patients, caregivers and patient advocacy organization representatives. Personal journeys and a number of topics were discussed, including the real human burden of NASH and the importance of the patient voice in clinical research. Thank you to everyone for your engagement, honesty, and feedback!?
-
Madrigal is proud to sponsor the Women’s Luncheon at the American Association for the Study of Liver Diseases (AASLD)'s The Liver Meeting? on November 18. The event is dedicated to helping female leaders in hepatology network, tackle challenges, and build a supportive community. #TLM24?
-
Did you know that the American Association for the Study of Liver Diseases (AASLD)’s Diversity, Equity and Inclusion committees are hosting a special social networking meet-up on November 16? Meet other meeting attendees interested in #diversity and #inclusion from 9:45 - 10:45 a.m. in the Sails Pavilion on the 2nd floor of the Convention Center.
-
Join us at American Association for the Study of Liver Diseases (AASLD)'s #TLM24 for two product theaters discussing a therapeutic option available for #NASH / #MASH patients with liver fibrosis.
-
As the American Association for the Study of Liver Diseases (AASLD) Liver Meeting approaches, our CEO, Bill Sibold, shares his enthusiasm and outlook for this year's event. Watch more below. #TLM24
With The Liver Meeting quickly approaching, it’s exciting to think about how far we've come in the past year. This American Association for the Study of Liver Diseases (AASLD) is particularly special, being the first with an approved product for #NASH / #MASH. I'm looking forward to learning about the advancements in this field and to showcasing the important work our Madrigal team has contributed. #TLM24
-
We're looking forward to engaging with the #liver community at the American Association for the Study of Liver Diseases (AASLD)'s #TLM24. Check out the #NASH / #MASH oral presentations we will be sharing.
Check Out Our Oral Presentations
-
Today, we stand with the Veterans of our community, expressing our gratitude for your service and sacrifice. We are proud to support Veterans and their families. Here, our own Carole Huntsman, Chief Commercial Officer, and Clint Wallace, Chief Human Resources Officer, both Veterans, reflect on the many transferrable skills they learned during their service and encourage other Veterans to apply to our open positions. Explore career opportunities and take the next step with us here: https://lnkd.in/eH9syce8 #VeteransDay
Explore Opportunities
-
Today, we stand with the Veterans of our community, expressing our gratitude for your service and sacrifice. We are proud to support Veterans and their families. Here, our own Carole Huntsman, Chief Commercial Officer, and Clint Wallace, Chief Human Resources Officer, both Veterans, reflect on the many transferrable skills they learned during their service and encourage other Veterans to apply to our open positions. Explore career opportunities and take the next step with us here: https://lnkd.in/eH9syce8 #VeteransDay
Explore Opportunities